Back to search

Alemtuzumab in T-Cell Malignancies

Data up to Jan 2025

Published2002
Citations66
References17

Total Citations Per Year

Abstract

References (17)

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

1997 • 531 citations

Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia

1991 • 474 citations

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1989 • 356 citations

Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor

1998 • 316 citations

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

2001 • 309 citations

Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H

1998 • 264 citations

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

1998 • 264 citations

Effect of Campath-1H antibody on human hematopoietic progenitors in vitro

1993 • 213 citations

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

1997 • 210 citations

PROLYMPHOCYTIC LEUKÆMIA OF B AND T CELL TYPE

1973 • 189 citations

The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.

1994 • 180 citations

Inactivation of the ATM Gene in T-Cell Prolymphocytic Leukemias

1998 • 158 citations

Indolent course as a relatively frequent presentation in T‐prolymphocytic leukaemia

1998 • 141 citations

Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia

1997 • 133 citations

In vivo‘Purging’ of residual disease in CLL with Campath‐1H

1997 • 94 citations

ATM is usually rearranged in T-cell prolymphocytic leukaemia

1998 • 92 citations

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies

1990 • 78 citations

Cited By (0)

No citing papers found in database

Alemtuzumab in T-Cell Malignancies (2002) – Medical Oncology | Metascience Observatory Explorer